Nothing Special   »   [go: up one dir, main page]

DE60001622D1 - Dihydrofuro-(3,4-b)-chinolein-1-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen - Google Patents

Dihydrofuro-(3,4-b)-chinolein-1-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE60001622D1
DE60001622D1 DE60001622T DE60001622T DE60001622D1 DE 60001622 D1 DE60001622 D1 DE 60001622D1 DE 60001622 T DE60001622 T DE 60001622T DE 60001622 T DE60001622 T DE 60001622T DE 60001622 D1 DE60001622 D1 DE 60001622D1
Authority
DE
Germany
Prior art keywords
alkyl
aryl
nr5r6
heteroaryl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60001622T
Other languages
English (en)
Other versions
DE60001622T2 (de
Inventor
Henri-Philippe Husson
Sylviane Giorgi-Renault
Christophe Tratrat
Ghanem Atassi
Alain Pierre
Pierre Renard
Bruno Pfeiffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of DE60001622D1 publication Critical patent/DE60001622D1/de
Application granted granted Critical
Publication of DE60001622T2 publication Critical patent/DE60001622T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60001622T 1999-11-24 2000-11-22 Dihydrofuro-(3,4-b)-chinolein-1-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen Expired - Fee Related DE60001622T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914771 1999-11-24
FR9914771A FR2801310B1 (fr) 1999-11-24 1999-11-24 NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (2)

Publication Number Publication Date
DE60001622D1 true DE60001622D1 (de) 2003-04-17
DE60001622T2 DE60001622T2 (de) 2004-02-05

Family

ID=9552476

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60001622T Expired - Fee Related DE60001622T2 (de) 1999-11-24 2000-11-22 Dihydrofuro-(3,4-b)-chinolein-1-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Country Status (22)

Country Link
US (1) US6548515B1 (de)
EP (1) EP1103554B9 (de)
JP (1) JP3566649B2 (de)
KR (1) KR100433705B1 (de)
CN (1) CN1157394C (de)
AT (1) ATE234305T1 (de)
AU (1) AU781300B2 (de)
BR (1) BR0005557A (de)
CA (1) CA2326710C (de)
DE (1) DE60001622T2 (de)
DK (1) DK1103554T5 (de)
EA (1) EA003996B1 (de)
ES (1) ES2194692T3 (de)
FR (1) FR2801310B1 (de)
HK (1) HK1036983A1 (de)
HU (1) HUP0004704A3 (de)
MX (1) MXPA00011240A (de)
NO (1) NO20005922L (de)
NZ (1) NZ508390A (de)
PL (1) PL344100A1 (de)
SI (1) SI1103554T1 (de)
ZA (1) ZA200006912B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2825091B1 (fr) * 2001-05-23 2003-07-04 Servier Lab Nouveaux derives tricycliques de dihydro-quinnoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2825092B1 (fr) * 2001-05-23 2005-01-14 Servier Lab Nouveau derives trycicliques de dihydro-quinoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN100376582C (zh) * 2006-04-26 2008-03-26 浙江大学 一种六氢呋喃[3,2-c]喹啉衍生物的制备方法
CN101092419B (zh) * 2006-06-23 2010-05-12 北京师范大学 (1z,4z,5z)-6-n-烷基-6-氮杂-2-氧代-3-氧杂-4-甲氧基-双环[3.1.0]己烷及其制备方法和用途
CN101092420B (zh) * 2006-06-23 2010-08-25 北京师范大学 (1z,4e,5z)-6-n-异丙基-6-氮杂-2-氧代-3-氧杂-4-甲氧基-双环[3.1.0]己烷及其制备方法和用途
US8927560B2 (en) 2010-12-06 2015-01-06 Council Of Scientific & Industrial Research 4-Aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
CA2936874A1 (en) 2014-01-15 2015-07-23 Guy Chabot Water soluble 4-azapodophyllotoxin analogs
WO2017151947A1 (en) * 2016-03-02 2017-09-08 George Robert Pettit 4-azapodophylotoxins compounds
CN110256457A (zh) * 2019-06-21 2019-09-20 江苏师范大学 一种4,7-二氢噻吩并[3,4-b]吡啶-5(1H)-酮化合物的合成方法
CN110684033B (zh) * 2019-09-06 2021-05-11 广西师范大学 四氢呋喃二喹啉化合物及其合成方法和应用
CN114989180B (zh) * 2022-05-26 2024-06-04 广东海洋大学 杨叶肖槿内生真菌来源的化合物及其制备方法与应用
US11731980B1 (en) 2023-03-22 2023-08-22 King Faisal University Furo[3,4-b]quinolone compounds as antibacterial agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310746A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen 1,4-dihydrochinolinen sowie ihre verwendung als arzneimittel
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
ATE161530T1 (de) * 1992-09-04 1998-01-15 Takeda Chemical Industries Ltd Kondensierte heterozyklische verbindungen, deren herstellung und verwendung
DE69422450T2 (de) * 1993-06-29 2000-06-08 Takeda Chemical Industries, Ltd. Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
WO1999008528A1 (en) * 1997-08-19 1999-02-25 Emory University Noscapine derivatives, useful as anticancer agents

Also Published As

Publication number Publication date
MXPA00011240A (es) 2002-05-23
HU0004704D0 (de) 2001-02-28
HUP0004704A2 (hu) 2001-11-28
KR100433705B1 (ko) 2004-05-31
JP2001151756A (ja) 2001-06-05
FR2801310B1 (fr) 2004-04-16
HK1036983A1 (en) 2002-01-25
KR20010051924A (ko) 2001-06-25
CA2326710A1 (fr) 2001-05-24
PL344100A1 (en) 2001-06-04
DK1103554T3 (da) 2003-07-14
DK1103554T5 (da) 2004-04-26
EP1103554A1 (de) 2001-05-30
BR0005557A (pt) 2001-07-17
ZA200006912B (en) 2001-06-05
HUP0004704A3 (en) 2003-11-28
FR2801310A1 (fr) 2001-05-25
SI1103554T1 (en) 2003-08-31
CA2326710C (fr) 2006-06-27
AU781300B2 (en) 2005-05-12
US6548515B1 (en) 2003-04-15
EA200001101A1 (ru) 2001-06-25
CN1302804A (zh) 2001-07-11
AU7182500A (en) 2001-05-31
NZ508390A (en) 2001-03-30
DE60001622T2 (de) 2004-02-05
ES2194692T3 (es) 2003-12-01
JP3566649B2 (ja) 2004-09-15
EA003996B1 (ru) 2003-12-25
EP1103554B1 (de) 2003-03-12
NO20005922D0 (no) 2000-11-23
NO20005922L (no) 2001-05-25
ATE234305T1 (de) 2003-03-15
CN1157394C (zh) 2004-07-14
EP1103554B9 (de) 2003-12-17

Similar Documents

Publication Publication Date Title
DE60001622D1 (de) Dihydrofuro-(3,4-b)-chinolein-1-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
AR030186A1 (es) Compuesto antibacteriano 3-aminoquinazolina-2,4-diona, composicion farmaceutica que lo comprende y su uso para fabricarla
HUP0203548A2 (hu) Új spirooxindolszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ZA9810330B (en) Chemical compounds
SE0101579D0 (sv) New compounds
AR042002A1 (es) Benzoxazinonas sustituidas, proceso de obtencion y usos para tratamiento de enfermedades del sistema nervioso central.
NO964698L (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
KR880001650A (ko) 트리아졸로피리딘 또는 트리아졸로퀴놀린의 신규 아미노알킬티오 유도체, 그의 제조방법 및 특히 진통제로서 유용한 그것이 존재하는 약제
HUT43067A (en) Process for preparing phenoxy-substituted beta-carboline derivatives further pharmaceutical compositions containing such compounds
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
ES2058275T3 (es) Derivados biciclicos de sulfonamida y su preparacion, su uso y formulaciones que los contienen.
HUP0103020A2 (hu) Heterociklusos származékok mint FKBP inhibitorok, eljárás az előállításukra, köztitermékeik és ezeket tartalmazó gyógyszerkészítmények
EA200301171A1 (ru) Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их
SE9002727L (sv) Nya aminopropanolderivat, foerfarande foer deras framstaellning samt farmaceutiska kompositioner innehaallande desamma
TW200510309A (en) Chemical compounds
PT916671E (pt) Novos inibidores de metaloproteases processo para a sua preparacao e as suas composicoes farmaceuticas que os contem
KR960022517A (ko) 1,2-가교화 1,4-디히드로피리딘의 약물 용도
PT1101756E (pt) Novos compostos de aminopirrolina processo para a sua preparacao e as composicoes farmaceuticas que os contem
EA200301172A1 (ru) Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их
EA200200379A2 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
NO955071L (no) abeo-Ergolin-derivater som 5HT1A-ligander
ATE233744T1 (de) Substituierte (dihydro)benzoxazin- und (dihydro)benzothiazinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DK44779A (da) 2-chlorsulfinylazetidin-4-on-forbindelser til anvendelse som mellemprodukter ved fremstilling af 3-exomethylencephamsulfoxider
HK1031380A1 (en) New benzoÄ3,4ÜcyclobutaÄ1,2-cÜpyrrole compounds, aprocess for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee